FDA News Release: November 8 (2023) Accessed online at: Last accessed June 22, 2024 von Elm E, Altman DG, Egger M, Pocock SJ, Gtzsche PC, Vandenbroucke JP, STROBE Initiative (2007) The strengthening the reporting of Observational studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
Additionally, the FDA maintains a medication shortage list, as long as the Semaglutide is listed a compounding pharmacy may compound semaglutide
Mounjaro is currently only approved to help regulate blood sugar levels in people with type 2 diabetes (T2DM), but clinical trials have shown significant weight loss as well
These facilities must register with the FDA, follow cGMP requirements, and submit to regular FDA inspections